Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Rahman syndrome (RMNS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous HIST1H1E variants and defined by the Rahman syndrome phenotype. Affected individuals exhibit a distinctive facial gestalt including macrocephaly, full cheeks, short neck, and low-set ears, accompanied by intellectual disability, hypotonia, anxiety, and autism spectrum behaviors.
The inheritance pattern is autosomal dominant, with most cases arising de novo and one documented mother–child transmission. To date, 48 unrelated probands (21 male, 27 female) with heterozygous frameshift mutations in the C-terminal tail of HIST1H1E have been reported (PMID:35156329). These variants uniformly truncate the protein, leading to loss of the normal C-terminal domain and generation of a novel frameshift tail.
Segregation analysis identified one additional affected first-degree relative, confirming familial transmission (PMID:35156329). The variant spectrum comprises exclusively small insertions or deletions creating a shared frameshift (e.g., c.368dup (p.Gly124ArgfsTer72)), consistent with a haploinsufficiency or dominant-negative mechanism.
A recent review curated 23 distinct HIST1H1E variants in 52 individuals, further delineating genotype–phenotype correlations. Common features included intellectual disability, hypotonia, anxiety, autism spectrum behaviors, and craniofacial dysmorphism, while variable expressivity was observed across different mutation sites (PMID:37605493).
Functional assays in rat hippocampal neurons expressing truncated H1.4 CTF proteins revealed dysregulation of ~400 transcripts enriched for synaptic and neuropeptide signaling pathways, alongside reduced neuronal firing rates on multielectrode arrays, supporting pathogenicity of C-terminal frameshift tails (PMID:34788807).
Collectively, the robust genetic and functional evidence meets a ClinGen “Strong” gene–disease association. Identification of frameshift HIST1H1E mutations should prompt clinical genetic testing for Rahman syndrome, enabling precise diagnosis and early intervention. Key take-home: HIST1H1E C-terminal frameshift variants underlie a distinct autosomal dominant neurodevelopmental syndrome with consistent facial, cognitive, and neurophysiological phenotypes.
Gene–Disease AssociationStrong48 probands with de novo or familial C-terminal frameshift variants; segregation in one family; concordant functional studies Genetic EvidenceStrong48 probands with heterozygous frameshift HIST1H1E variants impacting the C-terminal tail Functional EvidenceModerateNeuron models expressing H1.4 CTF show transcriptomic disruption and reduced neuronal activity ([PMID:34788807]) |